Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-κB Signaling Pathway

Table 3

Comparison of histopathological scores between Sham, HIR, and Vilda + HIR groups (%).

Parameters	Sham	HIR	Vilda + HIR
Sinusoidal congestion
Score 0	10 (100%)	0 (0%)	6 (60%)	37.5	<0.001
Score 1	0 (0%)	0 (0%)	4 (40%)
Score 3	0 (0%)	2 (20.0%)	0 (0%)
Score 4	0 (0%)	4 (40%)	0 (0%)
Score 5	0 (0%)	4 (40%)	0 (0%)
Hemorrhage
Score 0	10 (100%)	2 (20%)	10 (100%)	21.8	<0.05
Score 1	0 (0%)	4 (40%)	0 (0%)
Score 2	0 (0%)	2 (20%)	0 (0%)
Score 3	0 (0%)	2 (20%)	0 (0%)
Hepatocyte degeneration
Score 0	10 (100%)	0 (0%)	0 (0%)	43.0	<0.001
Score 1	0 (0%)	0 (0%)	2 (20%)
Score 2	0 (0%)	0 (0%)	2 (20%)
Score 3	0 (0%)	0 (0%)	2 (20%)
Score 4	0 (0%)	4 (40%)	2 (20%)
Score 5	0 (0%)	6 (60%)	2 (20%)
Parenchymal necrosis
Score 0	10 (100%)	0 (0%)	10 (100%)	30	<0.001
Score 4	0 (0%)	4 (40%)	0 (0%)
Score 5	0 (0%)	6 (60%)	0 (0%)